Pfizer and other drug companies have met with the Trump administration to discuss most-favored-nation pricing but no ...

Selective estrogen receptor modulators are advancing notably in treating hormone‐driven conditions, offering opportunities across oncology and women' ...

The report provides a detailed analysis of the current Type 2 diabetes marketed drugs and late-stage pipeline drugs. Elena ...